Stimatix, which makes products for colostomy management, is controlled by German healthcare company B. Braun Group, which is “refocusing” aspects of its product portfolio.
The Trendlines Group warns that a US$7.9 million write-off will send it into the red for it 1HFY2022 ended June 30.
The company, which invests in various start-ups, will impair the value of one of its portfolio companies Stimatix GI, in which it holds a 28.14% stake.
